The spleen is a lymphopoietic gland that plays an essential role in the reticuloendothial system. Although uncommon, the spleen can be the site of infectious and malignant diseases, such as lymphoma. 1 While cross-sectional imaging can help suggest a possible diagnosis, histological and immunochemical evaluation is generally necessary for definitive diagnosis. 2 Strategies to obtain splenic mass samples include surgery and percutaneous and endoscopic approaches. [3] [4] [5] Percutaneous ultrasound-guided biopsy is the standard technique for intra-abdominal organs; however, in experienced hands, endoscopic ultrasound (EUS)-guided biopsy can also be a safe and effective technique for acquiring tissue samples from intra-abdominal organs. 6 Utilizing proximity to the gastrointestinal tract, EUS provides a novel approach to sampling a splenic mass as the core biopsy needle traverses less tissue, and may reduce the risk of hemorrhage and hematoma. 5 Previously, evaluation using EUS-guided biopsy has been limited to cytodiagnosis with fine needle aspiration; however, the use of 19 G core biopsy needles maintains tissue integrity, allowing for immunochemical and histological assessment. Three patients underwent EUS-guided spleen biopsy (SB) for suspected lymphoma. The median age (range) of the 3 patients was 64 (37-77) years. EUS was performed using a standard linear-array echoendoscope (GF-UE180-AL5; Olympus America, Center Valley, PA, USA). EUS imaging is shown for all 3 patients in the Fig. 1 The median (range) length along the greatest sample dimension was 4.5 cm (3.9-7.1 cm). The median (range) number of cores obtained was 8 (8) (9) (10) (11) . The median (range) total specimen length and longest specimen length was 8.5 cm (8-8.5 cm) and 2.5 cm (2-2.5 cm), respectively. Immunochemical staining showed: CD 10+ and BCL-6+; CD 10-and BCL-2+; and CD10+, CD20+, Ki67+, IgH:MYCt (8:14) respectively, in the 3 patients. A definitive diagnosis of lymphoma was made in all patients and there were no complications using EUS-guided SB.
EUS has been described in the assessment of splenic masses but utilization consisted of fine-needle aspiration. 5, 8 Use of core biopsy needles for EUS-guided SB allows for acquisition of larger samples, and enables histological analysis and immunochemical staining. 7 By using a 19 G rather than a 22 G needle, our novel approach is associated with fewer passes and decreased risk bleeding while maximizing tissue quality. 9 Using a core needle, biopsies of the spleen have a sensitivity between 86-91% and a specificity between 91-97%. 4, 9 In comparing the complications of techniques used for evaluation of splenic masses, surgery is associated with the highest morbidity rates, probably because of infection. 10 At 8.2%, the estimated overall complication rate is lower in image-guided percutaneous spleen biopsy. 4 With use of smaller needles for image-guided percutaneous spleen biopsy, the complication rate decreases to 2.4%. 9 EUS-guided SB allows for not only direct evaluation of splenic masses, but also surrounding organs. The results of our study showed that EUS-guided SB in experienced hands can be safe and effective in the evaluation of splenic masses. EUS-guided core biopsy is an effective diagnostic approach in patients with splenic masses. Additional studies are needed to assess the safety of EUS-SB. 
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